Latest news
Analyst Reiterates Buy on AC Immune as 2H26 Catalysts Approach; Price Target Maintained at $12 - TipRanksTipRanks · Fri, 07 Aug 2026 12:49:47 GMTAC Immune (NASDAQ:ACIU) Announces Earnings Results, Misses Estimates By $0.09 EPS - MarketBeatMarketBeat · Wed, 05 Aug 2026 19:27:26 GMTOMERS ADMINISTRATION Corp Makes New Investment in Immunic, Inc. $IMUX - MarketBeatMarketBeat · Sun, 02 Aug 2026 09:31:47 GMTImmunic (IMUX) to Post Earnings on Thursday - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTImmunic (NASDAQ:IMUX) Upgraded to "Strong-Buy" at LADENBURG THALM/SH SH - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTPharming Group Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTAdaptive Biotechnologies Q2 Earnings Call Highlights - MarketBeatMarketBeat · Wed, 29 Jul 2026 22:06:34 GMTImmunic, Inc. (NASDAQ:IMUX) Receives Average Rating of "Buy" from Analysts - MarketBeatMarketBeat · Sun, 26 Jul 2026 07:00:00 GMT